rs1060501010
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_001330260.2(SCN8A):c.2627G>A(p.Gly876Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G876V) has been classified as Likely benign.
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile convulsions and choreoathetosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001330260.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN8A | NM_001330260.2 | MANE Select | c.2627G>A | p.Gly876Asp | missense | Exon 16 of 27 | NP_001317189.1 | ||
| SCN8A | NM_014191.4 | MANE Plus Clinical | c.2627G>A | p.Gly876Asp | missense | Exon 16 of 27 | NP_055006.1 | ||
| SCN8A | NM_001177984.3 | c.2627G>A | p.Gly876Asp | missense | Exon 16 of 26 | NP_001171455.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN8A | ENST00000354534.11 | TSL:1 MANE Plus Clinical | c.2627G>A | p.Gly876Asp | missense | Exon 16 of 27 | ENSP00000346534.4 | ||
| SCN8A | ENST00000627620.5 | TSL:5 MANE Select | c.2627G>A | p.Gly876Asp | missense | Exon 16 of 27 | ENSP00000487583.2 | ||
| SCN8A | ENST00000599343.5 | TSL:5 | c.2660G>A | p.Gly887Asp | missense | Exon 15 of 26 | ENSP00000476447.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The SCN8A c.2627G>A; p.Gly876Asp variant (ClinVar Variation ID 1794012) is reported in the literature in 2 individuals affected with epileptic encephalopathy (Peng 2022, Yang 2022). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses predict that this variant is deleterious (REVEL: 0.961). Based on available information, this variant is considered to be likely pathogenic. References: Peng BW et al. Genotype-phenotype correlations in SCN8A-related epilepsy: a cohort study of Chinese children in southern China. Brain. 2022 May 24. PMID: 35230384. Yang L et al. Use of medical exome sequencing for identification of underlying genetic defects in NICU: Experience in a cohort of 2303 neonates in China. Clin Genet. 2022 Jan. PMID: 34671977.
Inborn genetic diseases Uncertain:1
The p.G876D variant (also known as c.2627G>A), located in coding exon 15 of the SCN8A gene, results from a G to A substitution at nucleotide position 2627. The glycine at codon 876 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at